Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Olayinka Kamson
Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Related publications
High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma
Neurology
Neurology
Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated With Dose-Adjusted EPOCH Plus Rituximab
American Journal of Hematology
Hematology
Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy
Contrast Media and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Primary Central Nervous System Lymphoma: Coming or Going?
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Primary Central Nervous System Lymphoma
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Primary Central Nervous System Lymphoma
Contemporary Neurosurgery
Effect of Intravitreous Rituximab Injections in Patients With Recurrent Ocular Lesions Associated With Central Nervous System Lymphoma
Archives of Ophthalmology
Primary Central Nervous System Lymphoma With Lateral Ventricle Involvement
The Open Medical Imaging Journal
Primary Central Nervous System Lymphoma
Journal of Neurosurgery
Surgery
Neurology
